Romlusevimab (BRII-198) is a recombinant human IgG1 monoclonal antibody designed to specifically neutralize the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This targeted mechanism of action facilitates the inhibition of viral entry into host cells, offering potential therapeutic benefits in the treatment and prevention of COVID-19. Romlusevimab?€?s specificity and neutralizing capability make it a valuable tool in coronavirus research and therapeutic development.
Romlusevimab (BRII-198) is a recombinant human IgG1 monoclonal antibody designed to specifically neutralize the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This targeted mechanism of action facilitates the inhibition of viral entry into host cells, offering potential therapeutic benefits in the treatment and prevention of COVID-19. Romlusevimab?€?s specificity and neutralizing capability make it a valuable tool in coronavirus research and therapeutic development.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
